(Q33936735)

English

Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

meta-regression

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

Bruno Falissard

3

object named as

Bruno Falissard

0 references

author name string

Florian Naudet

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anne Solène Maria

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

8 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

e20811

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Accelerating response to antidepressant treatment in depression: a review and clinical suggestions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Performing meta-analysis with incomplete statistical information in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Observational versus experimental studies: what's the evidence for a hierarchy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

A reevaluation of the exclusion criteria used in antidepressant efficacy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Uses and abuses of meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

The ethics of placebo-controlled trials--a middle ground

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

A comparison of placebo responders and nonresponders in subgroups of depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Standardized regression coefficients: a further critique and review of some alternatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

28 July 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Observational versus randomised trial evidence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020811

21 January 2018

The fallacy of employing standardized regression coefficients and correlations as measures of effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110792

29 October 2018

When are observational studies as credible as randomised trials?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some observations on observational research

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative effectiveness assessment of listed drugs (REAL): a new method for an early comparison of the effectiveness of approved health technologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assuring That Double-Blind Is Blind

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0020811

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2011PLoSO...620811N

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33936735&oldid=1730919213"